In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

Background: Second-generation long-acting insulin glargine 300 U/mL (Gla-300) and degludec 100 U/mL (Deg-100) provide novel basal insulin therapies for the treatment of type 1 diabetes (T1D). Both offer a flatter pharmacokinetic (PK) profile than the previous generation of long-acting insulins, thus...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Technol Ther
Huvudupphovsmän: Schiavon, Michele, Visentin, Roberto, Giegerich, Clemens, Sieber, Jochen, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Materialtyp: Artigo
Språk:Inglês
Publicerad: Mary Ann Liebert, Inc., publishers 2020
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407002/
https://ncbi.nlm.nih.gov/pubmed/32125178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2020.0027
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk